These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19090995)

  • 1. Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
    Luo W; Rodina A; Chiosis G
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S7. PubMed ID: 19090995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
    Blair LJ; Sabbagh JJ; Dickey CA
    Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.
    Luo W; Dou F; Rodina A; Chip S; Kim J; Zhao Q; Moulick K; Aguirre J; Wu N; Greengard P; Chiosis G
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9511-6. PubMed ID: 17517623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
    Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
    Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones.
    Iqbal M; Lewis SL; Padhye S; Jinwal UK
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prions and chaperones: Outside the fold.
    Trivedi BP
    Nature; 2012 Feb; 482(7385):294-6. PubMed ID: 22337030
    [No Abstract]   [Full Text] [Related]  

  • 8. Hsp90 modulation for the treatment of Alzheimer's disease.
    Zhao H; Michaelis ML; Blagg BS
    Adv Pharmacol; 2012; 64():1-25. PubMed ID: 22840743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
    Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting chaperones in transformed systems--a focus on Hsp90 and cancer.
    Chiosis G
    Expert Opin Ther Targets; 2006 Feb; 10(1):37-50. PubMed ID: 16441227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 and the chaperoning of cancer.
    Whitesell L; Lindquist SL
    Nat Rev Cancer; 2005 Oct; 5(10):761-72. PubMed ID: 16175177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.
    Batko J; Antosz K; Miśków W; Pszczołowska M; Walczak K; Leszek J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP90 as a platform for the assembly of more effective cancer chemotherapy.
    Whitesell L; Lin NU
    Biochim Biophys Acta; 2012 Mar; 1823(3):756-66. PubMed ID: 22222203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hsp90--a target for anticancer therapy].
    Růcková E; Müller P; Vojtesek B
    Klin Onkol; 2011; 24(5):329-37. PubMed ID: 22070013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
    Smith JR; Workman P
    Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's disease treatment.
    Hurtado-Lorenzo A; Anand VS
    J Neurosci; 2008 Jul; 28(27):6757-9. PubMed ID: 18596151
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure, function and regulation of the hsp90 machinery.
    Li J; Buchner J
    Biomed J; 2013; 36(3):106-17. PubMed ID: 23806880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Hsp90 function in cancer: a unique therapeutic opportunity.
    Bagatell R; Whitesell L
    Mol Cancer Ther; 2004 Aug; 3(8):1021-30. PubMed ID: 15299085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
    Bohush A; Bieganowski P; Filipek A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells.
    Xu W; Neckers L
    Clin Cancer Res; 2007 Mar; 13(6):1625-9. PubMed ID: 17363512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.